Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses
about
Meat consumption and cancer risk.Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines.Multiple genetic alterations in human carcinogenesis.Exposure to heterocyclic amines.Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment.Lack of Hepatocarcinogenicity of Combinations of Low Doses of 2-amino-3, 8-dimethylimidazo[4,5- f ]quinoxaline and Diethylnitrosamine in Rats: Indication for the Existence of a Threshold for Genotoxic Carcinogens.2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis is not enhanced by CYP1A inducers, alpha- and beta-naphthoflavone: relationship to intralobular distribution of CYP1A expression.Selective in vitro binding of dietary mutagens, individually or in combination, by lactic acid bacteria.Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats.Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses.Synergistic enhancement of glutathione S-transferase placental form-positive hepatic foci development in diethylnitrosamine-treated rats by combined administration of five heterocyclic amines at low doses.Effects of chronic administration of low doses of 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline on glutathione S-transferase placental form-positive foci development in the livers of rats fed a choline-deficient diet.Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat.
P2860
Q33310049-16A66FC0-8FF4-474A-96DC-0F9AF1C81286Q33841604-6FF355EE-F6F0-4E40-ABC5-C85FC3083B01Q34843882-8981B216-E9DF-4DE0-BBDB-1B6228838415Q35031449-88D3495A-8AEF-4225-87AB-2ED39739C04CQ37839075-B40E5FC1-BCD8-473A-AA0C-DF7DF90782FAQ42323195-ACAEFA6D-A667-4AE8-9F8D-D15886BD282DQ43071510-8F406BB3-082C-46C0-873F-88A9F07F91FAQ43872034-4025075C-4202-4F98-B4E0-2DE1A821783FQ44961957-E6CF1343-C3F6-49F6-B270-22F527E374A0Q45915624-33CB99BA-BE6A-4012-823A-E644615A17F5Q53490257-DA80DE94-298C-4C4F-8CD4-FCF681A9505EQ53495120-D4F6D749-2314-49D4-85AE-68A403A8712CQ55007500-C60629B9-415C-4F08-BF8E-9D2E94BA480EQ55042256-71DBE60A-D992-47C2-9E50-086840EC2BDC
P2860
Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Enhancement of GST-P positive ...... terocyclic amines at low doses
@ast
Enhancement of GST-P positive ...... terocyclic amines at low doses
@en
Enhancement of GST-P positive ...... terocyclic amines at low doses
@nl
type
label
Enhancement of GST-P positive ...... terocyclic amines at low doses
@ast
Enhancement of GST-P positive ...... terocyclic amines at low doses
@en
Enhancement of GST-P positive ...... terocyclic amines at low doses
@nl
prefLabel
Enhancement of GST-P positive ...... terocyclic amines at low doses
@ast
Enhancement of GST-P positive ...... terocyclic amines at low doses
@en
Enhancement of GST-P positive ...... terocyclic amines at low doses
@nl
P2093
P356
P1433
P1476
Enhancement of GST-P positive ...... terocyclic amines at low doses
@en
P2093
K Wakabayashi
R Hasegawa
S Fukushima
T Sugimura
P304
P356
10.1093/CARCIN/12.5.767
P407
P577
1991-05-01T00:00:00Z